93602 ⎘
Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups , X being a hetero atom, Y being any atom Y being a hydrogen or a carbon atom
Sub-classes:KETONE INHIBITORS OF LYSINE GINGIPAIN
#2NOVEL COMPOUND FOR CAPPING LAYER AND ORGANIC LIGHT EMITTING DEVICE INCLUDING SAME
#3MODULATORS OF THE INTEGRATED STRESS PATHWAY
#4COMPOUND FOR CAPPING LAYER AND ORGANIC LIGHT EMITTING DEVICE INCLUDING SAME
#5Ketone inhibitors of lysine gingipain
#6MODULATORS OF THE INTEGRATED STRESS PATHWAY
#7Ketone inhibitors of lysine gingipain
#8Ketone inhibitors of lysine gingipain
#9Industrial process for the preparation of (5S, 10S)-10-benzyl-16-methyl-11, 14, 18-trioxo-15, 17, 19-trioxa-2,7,8-trithia-12-azahenicosan-5-aminium(E)-3-carboxyacrylate salt
#10Process For Preparation Of Vortioxetine Hydrobromide
#11Process of making prostacyclin compounds with linker thiol and pegylated forms
#12CETP activity inhibitors
#13Process for the preparation of cyclohexanecarboxylic acid derivatives
#14Small-molecule modulators of Trp-p8 activity
#15Process
#16Sphingosine kinase inhibitors
#17Compositions and methods for the treatment of disease associated with TRP-P8 expression
#18Small-molecule modulators of Trp-p8 activity
#19New Process
#20Derivatives of cycloalkyl- and cycloalkenyl-1,2-dicarboxylic acid compounds having formyl peptide receptor like-1 (FPRL-1) agonist or antagonist activity
#21NPY Y5 ANTAGONIST
#22NPY Y5 antagonist
#23CETP ACTIVITY INHIBITORS
#24Amide derivatives and medicinal use thereof
#25Process
#26Process for the preparation of CETP(1)
#27FLUOROSURFACTANTS
#28Small-molecule modulators of TRP-P8 activity
#29Sphingosine kinase inhibitors
#30PROCESS FOR THE PREPARATION OF CETP(1)
#31CETP activity inhibitors
#32Small-molecule modulators of TRP-p8 activity
#33NPY Y5 antagonist
#34Sphingosine kinase inhibitors
#35Non-steroidal farnesoid x receptor modulators
#36Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
#37Non-steroidal farnesoid X receptor modulators and methods for the use thereof
#38Compounds for inhibiting insulin secretion and methods related thereto
#39Benzene derivatives and pharmaceutical use thereof
#40Non-steroidal farnesoid X receptor modulators and methods for the use thereof
#41Compositions and methods for the treatment of disease associated with Trp-p8 expression